The history of Viagra offers a intricate case study for stakeholders eyeing drug companies. While first sales were astounding, recent patent lapse and the rise of cheaper versions have severely affected earnings. In https://caoimheucbp034829.blogproducer.com/48807991/the-blue-pill-and-big-pharma-a-risky-investment